Skip to main navigation Skip to search Skip to main content

232SM303 ASCEND clinical trial 'A Phase 3b Study to evaluate higher dose Nusinersen in Patients with Spinal Muscular Atrophy

Activity: Consultancy › Professional

Description

advisory services and training evaluators regarding the Endurance Shuttle Box and Block Test (ESBBT) and motor fatigability Tests
Period1 Sept 2021 → …
Work forBiogen IDEC, United States
Degree of RecognitionInternational